Login / Signup

Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model.

Yasmine Amr IssaSamar Nabil El AchyRasha Fadly Mady
Published in: Memorias do Instituto Oswaldo Cruz (2019)
Combining PZQ with CB1 receptor antagonists yielded the best results in reversing SSLF. To our knowledge, this is the first study to test this regimen in S. mansoni infection.
Keyphrases
  • liver fibrosis
  • healthcare
  • binding protein